Literature DB >> 24256894

Safety in Aflibercept versus Ranibizumab.

Takashi Ueta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24256894     DOI： 10.1016/j.ophtha.2013.09.019

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  1 in total

1.  Long-term outcome of intravitreal pegaptanib sodium as maintenance therapy in Japanese patients with neovascular age-related macular degeneration.

Authors:  Maiko Inoue; Kazuaki Kadonosono; Akira Arakawa; Shin Yamane; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2015-03-04       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.